AllDocs -> cancers

B reast cancer is the second lead- ing cause of cancer death in the world today, after lung cancer . According to the World Health Organization, more than one mil- lion people were expected to be diagnosed with breast cancer world- wide in 2004. 1 In the UK, it is the most common cancer in women, with an estimated 1 in 12 women at risk of developing the disease in their lifetime, 2 and between 35 000 and 41 000 new cases each year. As medicine enters the 21st cen- tury, the field of breast cancer con- tinues to reflect both our greatest successes and our greatest chal- lenges as scientists, epidemiologists and clinicians. Discoveries in the areas of breast cancer biology and genetics continue to help us refine our approach to the newly diag- nosed patient, as well as guide our development of cancer prevention ...

Singapore Med J 2002 Vol 43(10) : 533-538 R e v i e w A r t i c l e Diagnosis Disclosure in Cancer Patients – when the Family says “No!” A Lee, H Y Wu Palliative Care Service Department of Geriatric Medicine Tan Tock Seng Hospital 11 Jalan Tan Tock Seng Singapore 308433 A Lee, FRCP (Edin), FAMS Consultant H Y Wu, MRCP (UK) Registrar Correspondence to: Dr Angel Lee Tel: (65) 6357 7851 Fax: (65) 6357 7837 Email: lee_angel@ ttsh.com.sg ABSTRACT It is not uncommon for family members to thwart a doctor’s attempt at disclosure of cancer diagnosis to the patient.This stems from concern and love as well as fear of the negative psychological impact of such revelation. Indeed, collusion of this nature was the norm in medical practice till the not too distant past. ...

32 Abstract 19 Monday 10.10 Smoking cessation following cancer diagnosis Jamie L. Studts, PhD James Graham Brown Cancer Center and University of Louisville School of Medicine Louisville, Kentucky, USA While most individuals accept that smoking increases risk for several types of cancer , the benefits of smoking cessation following a cancer diagnosis are less commonly discussed. Among individuals newly diagnosed with smoking-linked malignancies of the lung, head, and neck, there are numerous incentives to quit smoking. Incentives include: (1) reduced risk of second primary malignancies, (2) improved quality of life, (3) fewer treatment-related symptoms, and (4) longer overall survival. Incentives to quit smoking exist for other malignancy groups as well, including improved wound healing following surgery, as well as cardiovascular, pulmonary, and overall physical functioning benefits. ...

MJA Vol 177 7 October 2002 347 RESEARCH The Medical Journal of Australia ISSN: 0025-729X 7 October 2002 177 7 347-351 ©The Medical Journal of Australia 2002 www.mja.com.au Research A ROUND 11 000 WOMEN are diagnosed with breast cancer in Australia each year. 1 About three-quarters are aged over 50 years, and many have menopau- sal symptoms. In addition, most chemo- therapies for breast cancer can cause ovarian dysfunction or premature menopause. For example, tamoxifen promotes vasomotor symptoms, despite oestrogen-like effects on the uterus and vagina. 2 Indeed, 60% of premenopausal women who receive adjuvant therapy for breast cancer subsequently have oes- trogen deficiency. 3,4 A significant reduction in menopausal symptoms and improvement ...

• BRIEF REPORTS • Autofluorescence excitation-emission matrices for diagnosis of colonic cancer Bu-Hong Li, Shu-Sen Xie ELSEVIER PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(25):3931-3934 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com © 2005 The WJG Press and Elsevier Inc. All rights reserved. Bu-Hong Li, Shu-Sen Xie, Biomedical Optics Laboratory, Institute of Laser and Optoelectronics Technology, Fujian Normal University, Fuzhou 350007, Fujian Province, China Supported by the Natural Science Foundation of Fujian Province, No. A0310018 and No. 2002F008, and the Scientific Research Program of Fujian Province, No. JA03041 Correspondence to: Dr. Bu-Hong Li, Biomedical Optics Laboratory, Institute of Laser and Optoelectronics Technology, Fujian Normal University, Fuzhou 350007, Fujian ...

1/53 DEA/DES in Bioinformatics 2003-2004 Thesis Breast Cancer Diagnosis Using Breast Cancer Diagnosis Using Microarray Microarray Benjamin Haibe-Kains Training Master: M. Christos Sotiriou Training Supervisor: M. Gianluca Bontempi Page 2 2/53 Table of Contents Introduction Introduction TransBIG Project TransBIG Project Materials Materials Populations Populations Microarray Platform Microarray Platform Methods and Results Methods and Results Development Tools Development Tools Quality Assessment Quality Assessment Supervised Classification Supervised Classification Gene Ontology Gene Ontology Discussion Discussion Future ...

Using GEMS for Cancer Diagnosis and Biomarker Discovery from Microarray Gene Expression Data Alexander Statnikov alexander.statnikov@vanderbilt.edu Ioannis Tsamardinos ioannis.tsamardinos@vanderbilt.edu Constantin F. Aliferis constantin.aliferis@vanderbilt.edu Discovery Systems Laboratory, Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA Keywords : gene expression microarray analysis, decision support systems, cancer , diagnosis , biomarker discovery. In this demonstration, we introduce a system called GEMS (Gene Expression Model Selector) for the automated development and evaluation of high-quality cancer diagnostic models and biomarker discovery from microarray gene expression data [1]. Traditional approaches to building such models (a) require specialized training in statistics, bioinformatics, or pattern recognition, (b) take several ...

CNA HealthPro From the Claim Files of CNA HealthPro: Missed Cancer Diagnosis We present a malpractice case history to educate readers about the risks faced by practitioners and the process of claims resolution. The patient, who had a history of sinusitis and nasal congestion, complained of right-side facial pain and swelling. After examining the area, Dr. X, a general dentist, told her the swelling she felt was an underlying bony projection. The dentist saw the patient on five subsequent occasions over the next year, each time reassuring her about the pain and swelling. The patient also saw her regular physician during this period, but did not communicate these complaints to him, as she thought her condition had been evaluated by her dentist. Seventeen months later, the condition was diagnosed as adenoid cystic carcinoma. The patient brought a lawsuit alleging that Dr. X was negligent in ...

Appendix for Paragraph 6 GLOUCESTERSHIRE HOSPITALS NHS TRUST Ultrasound used for the Diagnosis of Breast Cancer in Outpatients, Cheltenham General Hospital Page 1 Chief Executive’s Report, Main Board October 2003 ULTRASOUND USED FOR THE DIAGNOSIS OF BREAST CANCER IN OUTPATIENTS AT CHELTENHAM GENERAL HOSPITAL 1.0. PURPOSE 1.1. This paper requests an internal transfer of capital/leasing monies to replace an ultrasound machine supporting one stop breast cancer diagnosis . 2.0. BACKGROUND 2.1. Ultrasound has been used by surgeons in Cheltenham General Hospital outpatients for a number of years to support rapid diagnosis of breast cancer . 2.2. Two old machines were transferred from Linton House when this service was established these are now not working. A further machine was purchased 7 years ago, this is now unreliable. 2.3. ...

Medicine, Marathons & Miracles: Turning A Diagnosis of Cancer Into Personal Victory Kathy Cawthon, Roger Cawthon Ruby Press, Hampton, Virginia, $19.95, paperback, (156p) ISBN: 0-9770773-0-6 A diagnosis of the life-threatening cancer is a traumatic and scary experience for both the victim and the caregiver. For anyone whose life has been touched by this dreaded disease, "Medicine, Marathons & Miracles" is an uplifting, true-life story of Kathy and Roger Cawthon's remarkable triumph over their simultaneous battle with cancer . This courageous, upbeat couple share the lessons they learned in their ten-year journey since their dual diagnoses in order to "inspire and motivate other patients to move from being 'victims' to being 'victors'; and to illustrate that miracles really do happen." After thirteen years of marital bliss, Roger and Kathy were diagnosed with kidney and breast ...

ORIGINAL ARTICLE Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis C HRISTER B ORGFELDT 1 AND E LLIKA A NDOLF 2 From the 1 Department of Obstetrics and Gynecology, University Hospital, Lund, and the 2 Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden Acta Obstet Gynecol Scand 2004; 83: 395–400. # Acta Obstet Gynecol Scand 83 2004 Background. The aim was to evaluate whether patients with benign ovarian cysts, func- tional ovarian cysts, or endometriosis have an increased risk of developing gynecologic cancer . Methods. The Swedish Hospital Discharge Register was used to identify a cohort of women discharged from hospital with the diagnoses of ovarian cyst (n ¼ 42217), ...

Perceived Partner Reactions to Diagnosis and Treatment of Breast Cancer : Impact on Psychosocial and Psychosexual Adjustment Sarah R. Wimberly, Charles S. Carver, Jean-Philippe Laurenceau, Suzanne D. Harris, and Michael H. Antoni University of Miami Two studies examined breast cancer patients’ perceptions of their partners’ reactions to their diagnosis and treatment as influences on 3 aspects of patients’ well-being: psychosexual adjustment, emotional distress, and marital satisfaction. Study 1, cross-sectional, indicated that partner initiation of sex, frequency of sex, a positive 1st sexual experience after treatment, and especially perception of the partner’s emotional involvement in the relationship, were relevant to these outcomes. Study 2, longitu- dinal, confirmed many of these findings in prospective tests across 1 year of recovery after surgery. Partner involvement prospectively predicted all 3 outcomes. ...

Director General Armed Forces Medical Services & Senior Colonel Commandant, Army Medical Corps, Professor of Pathology, Army Hospital (R&R), Delhi Cantt-110010. Editorial “ Cancer biomarkers” constitutes one of the most rapidly advancing fields in clinical diagnostics. They can be used to screen asymptomatic individuals in the general population, to assist in early and specific diagnosis in suspect cases, to select patients who may benefit from specific treatments, to predict prognosis and response to therapy and finally to monitor patients after primary therapy. The introduction of advanced sophisticated technologies like microarray, mass spectrometry and automated DNA sequencing have opened new avenues in the field of “ Cancer biomarkers”. But by this world of mechanization, is light microscopy being lost in the thick dense forests? Let us critically analyze the assets ...

1 Now available Thry’vors Library of Visual Presentations, Lectures and TV Appearances Disk 001 “Thyroid Cancer – Diagnosis , Treatment and Aftercare” a Forum presented by the Burlington Hamilton Area Chapter of the Thyroid Foundation of Canada and Dell Pharmacy This 2 hour panel forum held in the Hamilton Spectator auditorium on September 24, 2003, includes presentations from the following individuals: 1. William Harper, MD, FRCP (C) Endocrinologist, Hamilton Health Sciences 2. Karen Gulenchyn, MD, FRCP (C) Chief, Nuclear Medicine, Hamilton Health Sciences 3. Stuart Archibald, FRCP (C) Head and Neck Surgical Oncologist, St. Josephs Healthcare Hamilton 4. Tom Smiley, B.Sc.Phm., Pharm.D. Dell Pharmacy, Brantford, Ontario 5. Rita Banach, B. Sc., DCS, President, Canadian Thyroid Cancer Support Group (Thry’vors) Inc. Dr. Harper’s gave an overview of Thyroid ...

A Sparse Solution Approach to Gene Selection for Cancer Diagnosis Using Microarray Data Yoonkyung Lee Department of Statistics The Ohio State University http://www.stat.ohio-state.edu/~yklee May 13, 2005 Page 2 Microarray Data Relative amount of mRNAs of tens of thousands of genes. (e.g. Affymetrix Human U133a GeneChips: 22K genes) Gene expression profiles as fingerprints at the molecular level. Potential for cancer diagnosis or prognosis. Examples Golub et al. (1999) Science : acute leukemia classification. Perou et al. (2000) Nature : breast cancer subclass identification. Van’t Veer et al. (2002) Nature : breast cancer prognosis. Page 3 Objectives and related issues Accurate diagnosis or prognosis. Interpretability. Subset selection or dimension reduction. Systematic ...

A heuristic approach in hepatic cancer diagnosis using a probabilistic neural network-based model Marina Gorunescu 1 , Florin Gorunescu 2 , Marius Ene 2 , and Elia El-Darzi 3 1 Faculty of Mathematics and Computer Science University of Craiova, 13 A.I. Cuza, Craiova, Romania (e-mail: gorun@euroweb.ro) 2 Department of Mathematics, Biostatistics and Computer Science University of Medicine and Pharmacy of Craiova, 2-4 Petru Rares, Craiova, Romania (e-mail: gorun@umfcv.ro, enem@umfcv.ro) 3 Harrow School of Computer Science University of Westminster, London Watford Road, Northwick Park, Harrow HA1 3TP, UK (e-mail: eldarze@wmin.ac.uk) Abstract. This paper is focusing on the application of a probabilistic neural network-based model in diagnosing hepatic diseases. In the diagnose process, the ...

28 April 2005 J. M. Le Goff, M. Streit-Bianchi CERN, Technology Transfer 1 PPARC Industry KITE Club Healthcare Technology Forum London, UK, April 28, 2005 CERN Technologies for Cancer Diagnosis & Therapy Transfer of Technologies from High Energy Physics to Member States Industry. Jean-Marie Le Goff Page 2 J. M. Le Goff, M. Streit-Bianchi – CERN – Technology Transfer 2 28 April 2005 PPARC Industry KITE Club Healthcare Technology Forum London, UK, April 28, 2005 Research Training Technology Collaborating CERN a place where Scientific and Technological knowledge is transferred to Industry and Society Page 3 J. M. Le Goff, M. Streit-Bianchi – CERN – Technology Transfer 3 28 April 2005 PPARC ...

Conquering the Curse of Dimensionality in Gene Expression Cancer Diagnosis : Tough Problem, Simple Models Minca Mramor 1 , Gregor Leban 1 , Janez Demsar 1 , and Blaz Zupan 1 , 2 1 Faculty of Computer and Information Science University of Ljubljana, Trzaska 25, Ljubljana, Slovenia 2 Department of Molecular and Human Genetics Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, U.S.A. Abstract. In the paper we study the properties of cancer gene expres- sion data sets from the perspective of classification and tumor diagnosis . Our findings and case studies are based on several recently published data sets. We find that these data sets typically include a subset of about 100 highly discriminating features of which predictive power can be further enhanced by exploring their interactions. This finding ...

Progress in Natuural Science Vol.15,No.4,April 2005 127 Diagnosis of prostate cancer by quantitative analysis of 3DMRSI data: A new model * QUAN Hong 1 , WANG Xiaoying 2 , BAO Shanglian 1** , WANG Huiliang 1 , LI Feiyu 2 and HUANG Rong 2 1. The Research Center for Tumor Diagnosis and Therapeutical Physics and the Beijing Key Laboratory of Medical Physics and Engineering, Peking University, Beijing 100871,China; 2. Department of Radiology, The First Affilated Hospital ,Peking University, Beijing, 100034,China Received July 30,2004; Revisal Abstract Three-dimensional magnetic resonance spectroscopic imaging (3DMRSI) is helpful to identify prostate cancer (PC) from benign prostate hyperplasia (BPH) and to show the distribution of tumor infiltration. ...

TECHNICAL REPORT, RENSSELAER POLYTECHNIC INSTITUTE, DEPARTMENT OF COMPUTER SCIENCE, TR-05-09. 1 Automated cancer diagnosis based on histopathological images: a systematic survey Cigdem Demir and Bulent Yener Abstract In traditional cancer diagnosis , pathologists examine biopsies to make diagnostic assessments largely based on cell morphology and tissue distribution. However, this is subjective and often leads to considerable variability. On the other hand, computational diagnostic tools enable objective judgments by making use of quantitative measures. This paper presents a systematic survey of the computational steps in automated cancer diagnosis based on histopathology. These computational steps are: 1.) image preprocessing to determine the focal areas, 2.) feature extraction to quantify the properties of these focal areas, and 3.) classifying the focal areas as malignant or not or identifying ...

16. New Drugs in Oncology / New Diagnosis and Modalities in Cancer Therapy PO442 ENZASTAURIN: CORRELATIONS OF CHEMOSENSITIVITY AND GENE EXPRESSION IN HUMAN SOLID TUMORS Eismann, U. 1 ; Oberschmidt, O. 1 ; Ehnert, M. 1 ; Fleeth, J. 1 ; Lüdtke , F.E. 1 ; Struck, S. 1 ; Schulz, L. 1 ; Blatter , J. 2 ; Lahn, M.M. 2 ; Ma, D. 2 ; Hanauske , A.-R. 1 1 Allgemeines Krankenhaus St. Georg, Hamburg; 2 Eli Lilly & Co, Indianapolis, USA Background: Enzastaurin is a potent and selective inhibitor for the beta-isoform of the protein kinase C (PKC-beta). The enzyme is implicated in processes that control tumor cell growth and survival. It is activated by several growth ...

Mayo Clin Proc. • October 2004;79(10):1277-1282 • www.mayo.edu/proceedings 1277 OVARIAN CANCER Ovarian Cancer : The Neglected Diagnosis ORIGINAL ARTICLE B ARBARA P. Y AWN , MD, MS C ; B RIGITTE A. B ARRETTE , MD; AND P ETER C. W OLLAN , P H D OBJECTIVE: To investigate presenting signs and symptoms of ovarian cancer and stage of tumor in a community cohort of women with the diagnosis of ovarian cancer . PATIENTS AND METHODS: We reviewed retrospectively the medi- cal records of all women who sought primary and specialty care in Olmsted County, Minnesota, between January 1, 1985, and De- cember 31, 1997, to evaluate presenting symptoms, time from first symptom to diagnosis of ovarian cancer , and stage of tumor ...

Breast Cancer Mayo Clin Proc, June 2004, Vol 79 810 Mayo Clin Proc . 2004;79:810-816 810 © 2004 Mayo Foundation for Medical Education and Research Concise Review for Clinicians Advances in Screening, Diagnosis , and Treatment of Breast Cancer B ETTY A. M INCEY , MD, AND E DITH A. P EREZ , MD From the Division of General Internal Medicine (B.A.M.), Multidis- ciplinary Breast Clinic (B.A.M., E.A.P.), and Division of Hematology and Oncology (E.A.P.), Mayo Clinic College of Medicine, Jackson- ville, Fla. A question-and-answer section appears at the end of this article. Individual reprints of this article are not available. Address corre- spondence to Edith A. Perez, MD, Division of Hematology and On- cology, Mayo Clinic College of Medicine, 4500 San Pablo Rd, ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN OSTEOSARCOMA / CHONDROSARCOMA CANCER TISSUE MICROARRAY Catalog Number: TMA-013 Each core from each tissue represents one specimen selected and pathologically confirmed. Normal matched or unmatched tissue is provided for comparison to the cancer tissue. Cases : 79 Cores : 80 Diameter : 1.5 mm Thickness: 5 µm Standard IHC: Anti-proliferating cell nuclear antigen antibody confirmed Layout : 8 x 10 1 2 3 4 5 6 7 8 9 10 A 1 2 3 4 5 6 7 8 9 10 B 11 12 13 14 15 16 17 18 19 20 C 21 22 23 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LUNG CANCER TISSUE MICROARRAY Catalog Number: TMA-001 Each core from each tissue represents one specimen selected and pathologically confirmed. Normal adjacent lung tissue is placed next to its matched or unmatched cancer tissue. Cases : 56 Cores : 100 Diameter : 1 mm Thickness: 5 µm Standard IHC: Cytokeratin confirmed Layout : 10 x 10 1 2 3 4 5 6 7 8 9 10 A 1 2 3 4 5 6 7 8 9 10 B 11 12 13 14 15 16 17 18 19 20 C 21 22 23 24 25 26 27 28 29 30 D ...

CASE NOTE 02HDC08972: Missed early diagnosis of stomach cancer Right to services of an appropriate standard – Reasonable care and skill – General practitioner – Missed diagnosis – Cancer – Stomach – Peptic ulcer disease – Investigations – Gastroscopy – Right 4 A complaint was made by Mrs A that her GP did not provide services of an appropriate standard. The complaint was on the basis that (1) after a normal barium meal investigation the GP did not order any further investigations, although Mrs A continued to complain of abdominal pain and vomiting; (2) that the GP did not refer her for specialist assessment when her symptoms continued and her general health deteriorated; and (3) the GP did not discuss with her the option of gastroscopy. The facts were that between March 1998 and 2000 Mrs A consulted the GP on a number of occasions relating to gastrointestinal symptoms. On two occasions, ...

CASE NOTE 01HDC00389: Missed diagnosis of ovarian cancer Right to services of an appropriate standard – Reasonable care and skill – Compliance with professional standards – General practitioner – Missed diagnosis – Cancer – Ovarian – Gynaecology – Clinical examination – Record keeping – NZMA Code of Ethics – Right 4(1) – Right 4(2) A complaint was made by a consumer about the care she received from a general practitioner. The complaint was on the basis that the general practitioner did not adequately examine the consumer, did not diagnose ascites, and did not refer her for further tests or assessment. The facts were that the consumer visited the GP for her annual vaginal smear. The GP did not examine her abdomen for lumps. Two months later the consumer returned after noticing a lump in her abdomen, and for a prescription to treat recurrence of her reflux oesophagitis. The GP informed her that the lump, viewed ...

Improved Breast Cancer Diagnosis through Decision Fusion Anna Leigh Rack-Gomer Department of Electrical Engineering Duke University Advisor: Dr. Loren Nolte, Professor of Electrical and Biomedical Engineering Abstract With the introduction of several new modalities for the detection of breast cancer , it has become even more important to implement computer-aided diagnostic models to help generate the best decisions from multiple tests, particularly when including multimodal data sets such as a mammogram and gene expression profile. Decision fusion provides a statistical model that can best combine information from multiple tests, by taking into account the performance of each diagnostic as a detector of breast cancer . To show this, the promoter methylation levels of five specific genes (proven biomarkers of breast cancer ) were analyzed in 19 known tumor tissue samples ...

www.imego.com Imego AB, Arvid Hedvalls Backe 4, SE-411 33 Gothenburg, Sweden Tel. +46 (0) 31 750 18 00. Fax. +46 (0) 31 750 18 01 Diagnosis of prostate cancer A fast and simple diagnosis of cancer decreases hospital care costs and permits mass screening of populations, and thereby, earlier diagnoses.The need for such an instrument exists in particular when it comes to diagnosing prostate cancer .The appearance of prostate cancer has increased dramatically, and great amounts of resources are being placed in treatment. Early diagnosis would be accompanied in part by large economic savings for society and, in another part, would contribute to improved life quality for patients whose treatment would be considerably more merciful. Working together, Imego AB and CanAg Diagnostic AB are developing a new chip based analysis instrument for quantity detection of cancer . It will replace ...